Skip to content
Lower risk Medical device recall · FDA · Published November 20, 2023

Randox Calibration Serum Level 3 CAL2351 recall: 13% test accuracy shift risk

Randox recalls Calibration Serum Level 3 CAL2351 (lot numbers 1214UE-1315UE) due to potential 13% shift in test accuracy on RX Series instruments. Affected users should contact Randox for guidance.

🇺🇸 FDA recall #Z-0752-2024Medical deviceRandox ›
Take action

Contact the company

Recalling firmRandox Laboratories Ltd.55 Diamond Road · Crumlin (North), Ireland
✎ GovInfoNow plain-language explainer

Randox is recalling Calibration Serum Level 3 CAL2351 because it may cause up to 13% shifts in test accuracy when used with RX Series instruments. This could lead to incorrect patient results if not addressed. Read more at govinfonow.com/recall/56798-randox-calibration-serum-level-3-cal2351-recall-13-test-accuracy.

Source Summary by GovInfoNow · govinfonow.com/recall/56798-randox-calibration-serum-level-3-cal2351-recall-13-test-accuracy · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0752-2024

Cite this page

“Randox Calibration Serum Level 3 CAL2351 recall: 13% test accuracy shift risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/56798-randox-calibration-serum-level-3-cal2351-recall-13-test-accuracy. Based on FDA recall #Z-0752-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0752-2024%22&limit=1).

The FDA announced on November 20, 2023, that Randox Laboratories Ltd. is recalling Calibration Serum Level 3 CAL2351 due to a positive bias in CK Total readings. This defect can cause shifts in quality control and patient sample recovery of up to 13% on RX Series instruments.

How to tell if you have it

  • Brand: Randox
  • Product: Calibration Serum Level 3 CAL2351
  • UPC: 05055273200966
  • Lot Numbers: 1214UE, 1249UE, 1260UE, 1262UE, 1268UE, 1297UE, 1298UE, 1315UE

The hazard

According to the FDA, CK Total in Calibration Serum Level 3, CAL2351, is running with a positive bias on RX Series instruments. This issue may cause a shift in Quality Control and patient sample recovery of up to 13% compared to other methods.

Context

GovInfoNow's records show Randox Laboratories Ltd. has 49 other recalls on record since June 7, 2017. Recent similar recalls include the Randox Clinical Chemistry Calibration Serum Recall dated March 5, 2024, which involved an inorganic phosphate bias issue, and the Randox Cystatin C Reagent Recall dated June 7, 2024, for missing FDA 510(k) clearance. Other recent recalls of similar products include the Siemens Healthcare Syva Emit Tox Serum Calibrators Recall (June 26, 2026), the Siemens Dimension Tacrolimus Flex Reagent Cartridge Recall (May 7, 2026), and the Beckman Coulter Access Total T4 Calibrator Recall (March 16, 2026).

How to tell if you have this one

Check for lot numbers 1214UE, 1249UE, 1260UE, 1262UE, 1268UE, 1297UE, 1298UE, or 1315UE on the product label. The product is sold under the brand Randox Laboratories Ltd.

  • Brand
    Randox
  • Product
    Calibration Serum Level 3 CAL2351
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Contact Randox

    Reach out to Randox Laboratories Ltd. for specific guidance on handling the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “US Nationwide and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Nov 20, 202312. FDA classified it Class II: Jan 18, 202423. Published in FDA’s Enforcement Report: Jan 24, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product dangerous to use?

The recall indicates a potential 13% shift in test accuracy, but it does not pose a direct safety risk like injury or fire. The hazard is related to test accuracy, not physical harm.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0752-2024 (November 20, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0752-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA